"Virus Internalization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane.
| Descriptor ID |
D053586
|
| MeSH Number(s) |
G06.920.881
|
| Concept/Terms |
Virus Membrane Fusion- Virus Membrane Fusion
- Viral Membrane Fusion
- Fusion, Viral Membrane
- Membrane Fusion, Viral
|
Below are MeSH descriptors whose meaning is more general than "Virus Internalization".
Below are MeSH descriptors whose meaning is more specific than "Virus Internalization".
This graph shows the total number of publications written about "Virus Internalization" by people in this website by year, and whether "Virus Internalization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 3 | 1 | 4 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 2 | 5 |
| 2011 | 5 | 0 | 5 |
| 2012 | 5 | 0 | 5 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 3 | 4 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 1 | 4 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 4 | 6 |
| 2021 | 4 | 5 | 9 |
| 2022 | 0 | 5 | 5 |
| 2023 | 1 | 2 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Virus Internalization" by people in Profiles.
-
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula. Cancer Lett. 2024 Nov 01; 604:217198.
-
Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency. Am J Vet Res. 2023 Sep 01; 84(9).
-
CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 02 28; 14(1):1148.
-
CDK4/6 inhibitor palbociclib promotes SARS-CoV-2?cell entry by down-regulating SKP2 dependent ACE2 degradation. Antiviral Res. 2023 04; 212:105558.
-
Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2. J Food Biochem. 2022 10; 46(10):e14354.
-
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. Cell Rep. 2022 05 24; 39(8):110859.
-
Identification of functionally important domains of human cytomegalovirus gO that act after trimer binding to receptors. PLoS Pathog. 2022 04; 18(4):e1010452.
-
A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development. Commun Biol. 2022 03 08; 5(1):212.
-
Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2. J Biol Chem. 2022 03; 298(3):101658.
-
Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection. Mol Ther. 2022 05 04; 30(5):1966-1978.